Pharmaceuticals APAC News & Press Release Distribution

Pharmaceuticals

All
Global

JW Therapeutics and 2seventy bio Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies

* Initial focus on accelerating development of 2seventy's MAGE-A4 program in solid tumors inChina SHANGHAI, China and CAMBRIDGE, Mass., Oct. 27, 2022 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and comme...

2022-10-27 07:53 3288

Telix and UniQuest to Collaborate on Radiolabelled Immune Targeting Peptide

MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a collaboration with UniQuest Pty Ltd (UniQuest), the commercialisation company of TheUniversity of Queensland (UQ), to develop a radiolabelled molecule targeting an im...

2022-10-27 06:44 2246

Ascletis Announces U.S. IND Filing of Oral Antiviral ASC10 for Monkeypox Indication

--ASC10 has two indications: monkeypox and SARS-CoV-2 virus infections. The Investigational New Drug (IND) application of the latter was approved by the U.S. Food and Drug Administration (FDA) inAugust 2022 and Phase Ib clinical trial in COVID-19 patients is underway in the U.S. --Preclinical st...

2022-10-26 20:10 2171

First satellite bioanalytical lab offers fastest option for PBMC processing in Australian clinical trials

THEBARTON, Australia, Oct. 26, 2022 /PRNewswire/ -- On 09 September 2022, Australia welcomed its first bioanalytical laboratory inside a Phase 1 clinical unit. Agilex Biolabs, Australia's largest bioanalytical laboratory, has established its first satellite processing unit on the fifth floor o...

2022-10-26 17:00 889

MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval

GENEVA, Oct. 25, 2022 /PRNewswire/ -- Following our communication last week "MedAlliance to be acquired by Cordis",MedAlliance is pleased to make the following announcement: SELUTION SLR™, MedAlliance's novel sirolimus...

2022-10-25 08:00 2405

MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval

Transcenta to Participate in Four Upcoming Conferences

SUZHOU, China, Oct. 24, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical-stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development, and manufacturing of antibody-based therapeutics, announces that the management ...

2022-10-24 21:00 3506

Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19

HONG KONG, Oct. 24, 2022 /PRNewswire/ -- A randomised, double-blind controlled study conducted by TheChinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) showed that SIM01, a CUHK-developed microbiome formula, successfully reduced adverse events in high-risk individuals such...

2022-10-24 17:59 2705

Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19

U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults

GAITHERSBURG, Md., Oct. 22, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received eme...

2022-10-22 03:25 7079

Antengene Announces XPOVIO® Regulatory Approval in Taiwan for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma

- XPOVIO® is the first and only exportin 1 (XPO1) inhibitor approved in Taiwan - Antengene plans to submit for national health insurance reimbursement inTaiwan for XPOVIO® in Q4 2022 SHANGHAI and HONG KONG, Oct. 21, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEH...

2022-10-21 20:37 4663

SIRONA completes enrollment - A leap in the DCB treatment of femoropopliteal arterial disease

TAMPA, Fla., Oct. 21, 2022 /PRNewswire/ -- Concept Medical Inc. announces the successful completion of the SIRONA - World's first and the largest head-to-head RCT investigating the use of Sirolimus Drug Coated Balloon (DCB) (Magic Touch PTA

2022-10-21 20:36 3043

SIRONA completes enrollment - A leap in the DCB treatment of femoropopliteal arterial disease

MGI Contributes to Thailand's Roadmap for Genomic Medicine in Genomics Thailand Initiative

BANGKOK, Oct, 21 2022 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today announced the supply of its products* to support the sequencing of the genomes of 50,000 Thai individuals as part of the Genomics Thailand Initiativ...

2022-10-21 11:00 2835

SI GROUP LAUNCHES NEW BRAND FOR PLASTICS RECYCLING AT K 2022

EVERCYCLE™ solutions advance the plastics industry's transition towards a circular economy THE WOODLANDS, Texas, Oct. 21, 2022 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals, and chemical intermediates, unveiled ...

2022-10-21 00:15 2211

Grand Opening of 'Medlab Asia & Asia Health 2022' in Thailand

BANGKOK, Oct. 20, 2022 /PRNewswire/ -- Thailand's Minister of Public Health officiates Medlab Asia & Asia Health 2022, the leading trade exhibition within the medical laboratory industry in the ASEAN region, organised by Informa Markets and IMPACT Exhibition Management, attracting over 11,000 par...

2022-10-20 16:48 2103

Grand Opening of 'Medlab Asia & Asia Health 2022' in Thailand

ALFASIGMA ACQUIRES SOFAR'S ENTIRE SHARE CAPITAL, AN ITALIAN PHARMACEUTICAL COMPANY

POMEZIA, Italy, Oct. 20, 2022 /PRNewswire/ -- Alfasigma S.p.A. has completed the acquisition of SOFAR S.p.A., thus officially beginning the integrating process of the two companies. The transaction, which was launched last August and was scheduled for completion inOctober 2022, was success...

2022-10-20 14:45 1484

Millions of Women who Suffer from Pelvic Pain Still Unaware of Pelvic Venous Congestion Syndrome PVCS

SYDNEY, Oct. 20, 2022 /PRNewswire/ -- Pelvic pain is a common condition affecting millions of women around the world, with up to 40% affected during their lifetime. Of those affected, 30% suffer from Pelvic Venous Congestion Syndrome (PVCS). Boston Scientific haslaunched a new website

2022-10-20 10:00 1683

Telix Reports Third Quarter 2022 Financial Results

MELBOURNE, Australia, Oct. 20, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended30 September 2022 (Q3 2022). All figures are in AUD$ unless otherwise...

2022-10-20 06:09 1478

Everest Medicines Announces Partner Providence Reports Positive Top-Line Data from Phase 2 Primary Immunization Trial for mRNA COVID-19 Vaccine Candidate in Adults

-- Levels of neutralizing antibodies generated by PTX-COVID19-B were non-inferior to Comirnaty®-- -- PTX-COVID19-B was well tolerated with no safety signals-- -- Everest is filing IND applications for phase 3 clinical trials for booster indication-- SHANGHAI, Oct. 19, 2022 /PRNewswire/ -- Everest...

2022-10-19 20:15 1979

Brii Biosciences Presents Promising Clinical Data to Support Ongoing Development of Novel HIV Therapeutic Candidates at IDWeek 2022

* Findings from two Phase 1 studies show both BRII-732 and BRII-778 are safe and well-tolerated * Results indicate potential for oral once-weekly, long-acting combination therapy for HIV infection, supporting continued clinical development * Additional data presented by Brii's licensing part...

2022-10-19 20:00 1770

MedAlliance to be Acquired by Cordis

GENEVA, Oct. 19, 2022 /PRNewswire/ -- Swiss-based medical technology company MedAlliance has announced it has entered into an agreement with Cordis for an acquisition which includes an initial investment of$35M and upfront closing payment of$200M, regulatory achievement milestones of up to $125M ...

2022-10-19 08:00 1695

Rhovac board member resigns due to health reasons

LUND, Sweden, Oct. 18, 2022 /PRNewswire/ -- RhoVac AB (publ) announces today, October 18th 2022, that board member and co-founder Anders Ljungqvist is resigning from the board at his own request due to health reasons. Gunnar Gårdemyr, chairman of the board, comments: "On behalf of the board, I w...

2022-10-18 21:29 1227

1 ... 55 56 575859 60 61 ... 180